Thyrocare Sells Radiology Arm for ₹1414 Cr, Acquires CCPS

Thyrocare Technologies Ltd announced the approval by its Board of Directors to sell its entire stake in its wholly-owned subsidiary, Nueclear Healthcare Limited (NHL), to Trovera Healthcare Private Limited for approximately ₹1414 crore. This divestment marks Thyrocare's exit from the radiology business to focus on its core pathology operations. The consideration includes ₹59.50 crore in Compulsorily Convertible Preference Shares (CCPS) of Trovera and ₹81.90 crore in cash, subject to adjustments. The company will acquire these CCPS as part of the deal. The transaction is subject to shareholder approval and regulatory clearances. NHL will cease to be a subsidiary post-completion.